Strategic Communication and Public Relations

Oxidative stress: Alternative utilization of glucose ensures survival of the cell

No. 03 | 15/01/2015 | by Koh

Oxidative stress in the cell blocks the normal sugar metabolism. Scientists from the German Cancer Research Center (DKFZ) and the Heidelberg Institute for Theoretical Studies (HITS) have now found out that this long known interruption of the normal sugar metabolism under stress conditions is not an uncontrolled disruption. On the contrary, it is vital for the survival of the cells. It is based on a highly specific mechanism that formed early during evolution and can even be found in bacteria. Cancer cells may particularly benefit from this mechanism.

© BirgitH pixelio.de

Glucose provides energy and components for the cells in our body. Scientists have known for many years that the normal breakdown of glucose is disrupted under oxidative stress as can arise, for example, in inflammatory or toxic processes. The reason for this is that one of the key enzymes in glucose breakdown, GAPDH (glycerinaldehyde 3-phosphate dehydrogenase), is oxidized extremely rapidly and efficiently by hydrogen peroxide (H2O2) and is inactivated in the process. In chronic inflammatory reactions, immune cells permanently release H2O2 – a characteristic of oxidative stress.

But why is it that GAPDH is inactivated by hydrogen peroxide much more easily and rapidly than other enzymes? And what does the interruption of the glucose breakdown mean for the cell? “Until now, scientists have believed that the oxidative inactivation of GAPDH is just an inevitable side effect of its generally high reactivity,” says Tobias Dick from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).”To break down glucose efficiently, the GAPDH enzyme has a highly reactive center, which reacts non-specifically with H2O2 and thereby inhibits itself," says Dick, describing the commonly used explanation of this phenomenon. Thus, it has been presumed until now that for the cell to produce energy from glucose efficiently, it has to put up with the fact that the glucose metabolism is disrupted in the case of oxidative stress.

In a collaboration with a team headed by Frauke Gräter from the Heidelberg Institute for Theoretical Studies (HITS) and colleagues from the National Institute of Oncology in Budapest, Dick’s working group has now shown that the contrary is the case: The scientists have discovered a previously unknown mechanism that specifically induces the reaction of GAPDH with H2O2.

Using laboratory experiments and computer simulations, the researchers found out that the high sensitivity of GAPDH to H2O2 is not a side effect of GAPDH’s general reactivity, as scientists have believed until now. Instead, GAPDH accelerates its own oxidative inactivation in a specific process that is independent of its activity in the glucose metabolism.

“We were surprised to discover that this special mechanism can be found in the GAPDH of almost all life forms, from bacteria to man. All this suggested that it plays a fundamental role for survival under stress conditions,” Dick explains.

The scientists generated a genetically modified GAPDH that fully retains its normal glycolytic activity without being sensitive to inhibition by H2O2. In yeast strains, they replaced the normal enzyme by the oxidation-insensitive variant. No differences were observed under normal conditions, i.e., glucose metabolism and cell growth were the same with both variants.

Under oxidative stress, however, the cells with the normal oxidation-sensitive GAPDH had a significant advantage for growth: As the researchers demonstrated, the oxidative blocking of GAPDH led to an alternative utilization of glucose. This alternative path primarily promoted the formation of NADPH, a molecule that counteracts oxidation and helps the cell cope with oxidative stress. Thus, the disruption of the normal glucose metabolism in the cell generates a key advantage for survival. This also explains why the mechanism of oxidative inactivation of GAPDH formed early in the evolution of organisms and has been conserved to the present day.

In a next step, the researchers plan to investigate whether cancer cells may also benefit from oxidative inactivation of GAPDH. David Peralta, the first author of the study, explains: “Cancer cells use particularly high amounts of glucose and additionally are under oxidative stress. We therefore presume that they use oxidative inactivation of GAPDH for their own purposes. By switching off this mechanism, we might hit cancer cells extremely hard.”

David Peralta, Agnieszka K Bronowska, Bruce Morgan, Éva Dóka, Koen Van Laer, Péter Nagy, Frauke Gräter, Tobias P Dick (2015). A proton relay enhances H2O2 sensitivity of GAPDH to facilitate metabolic adaptation. Nature Chemical Biology 2015, DOI: 10.1038/nchembio.1720

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institution in Germany. More than 1,300 scientists at the DKFZ investigate how cancer develops, identify cancer risk factors and search for new strategies to prevent people from developing cancer. They are developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to all questions on cancer.

Jointly with partners from the university hospitals, the DKFZ operates the National Center for Tumor Diseases (NCT) in Heidelberg and Dresden, and the Hopp Children's Tumour Center KiTZ in Heidelberg. In the German Consortium for Translational Cancer Research (DKTK), one of the six German Centers for Health Research, the DKFZ maintains translational centers at seven university partner locations. NCT and DKTK sites combine excellent university medicine with the high-profile research of the DKFZ. They contribute to the endeavor of transferring promising approaches from cancer research to the clinic and thus improving the chances of cancer patients.

The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS